Barclays’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Sell
2
-4,436
-100% ﹤0.01% 4604
2025
Q1
$19K Buy
4,438
+1,437
+48% +$6.15K ﹤0.01% 4071
2024
Q4
$21K Sell
3,001
-133
-4% -$931 ﹤0.01% 4108
2024
Q3
$45K Buy
3,134
+2,513
+405% +$36.1K ﹤0.01% 3938
2024
Q2
$45K Sell
621
-838
-57% -$60.7K ﹤0.01% 3709
2024
Q1
$86K Sell
1,459
-1,405
-49% -$82.8K ﹤0.01% 3693
2023
Q4
$210K Buy
2,864
+2,501
+689% +$183K ﹤0.01% 3486
2023
Q3
$14K Sell
363
-54
-13% -$2.08K ﹤0.01% 3977
2023
Q2
$24K Sell
417
-1,275
-75% -$73.4K ﹤0.01% 3936
2023
Q1
$110K Buy
+1,692
New +$110K ﹤0.01% 3473
2022
Q2
Sell
-213
Closed -$17K 4935
2022
Q1
$17K Sell
213
-1,377
-87% -$110K ﹤0.01% 4372
2021
Q4
$146K Buy
1,590
+1,055
+197% +$96.9K ﹤0.01% 2898
2021
Q3
$67K Buy
535
+364
+213% +$45.6K ﹤0.01% 3333
2021
Q2
$20K Sell
171
-869
-84% -$102K ﹤0.01% 3726
2021
Q1
$157K Buy
1,040
+638
+159% +$96.3K ﹤0.01% 3218
2020
Q4
$46K Sell
402
-175
-30% -$20K ﹤0.01% 3208
2020
Q3
$44K Sell
577
-113
-16% -$8.62K ﹤0.01% 3335
2020
Q2
$76K Buy
690
+263
+62% +$29K ﹤0.01% 3232
2020
Q1
$46K Sell
427
-863
-67% -$93K ﹤0.01% 3132
2019
Q4
$205K Buy
1,290
+654
+103% +$104K ﹤0.01% 3161
2019
Q3
$94K Sell
636
-195
-23% -$28.8K ﹤0.01% 3434
2019
Q2
$97K Buy
831
+374
+82% +$43.7K ﹤0.01% 3604
2019
Q1
$50K Buy
+457
New +$50K ﹤0.01% 3650
2018
Q4
Sell
-217
Closed -$35K 4413
2018
Q3
$35K Buy
+217
New +$35K ﹤0.01% 3835